We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B Turnover 6.98%
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
-3.21%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$2.3B
AUM Growth
+$222M
Cap. Flow
+$315M
Cap. Flow %
13.7%
Top 10 Hldgs %
30.03%
Holding
391
New
14
Increased
187
Reduced
112
Closed
16
Avg Time Held
5.1 years
Top 10 Avg Time Held
3.1 years
Top 20 Avg Time Held
2.2 years

Top Buys

Rank Stock Value
1
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$157M
2
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$27.5M
3
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$20.5M
4
BND icon
Vanguard Total Bond Market
BND
+$17.1M
5
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$14.8M

Top Sells

Rank Stock Value
1
RS icon
Reliance Steel & Aluminium
RS
+$2.36M
2
HD icon
Home Depot
HD
+$1.68M
3
VWOB icon
Vanguard Emerging Markets Government Bond ETF
VWOB
+$1.33M
4
MZTI icon
The Marzetti Company
MZTI
+$1.04M
5
JNJ icon
Johnson & Johnson
JNJ
+$1.04M

Sector Composition

Rank Sector Weight
1 Miscellaneous 45.03%
2 Technology 13.2%
3 Healthcare 9.36%
4 Financials 7.78%
5 Consumer Staples 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
INTC icon
76
Intel
INTC
$479B
$8.49M 0.37%
171,218
-2,748
-2% -$136K
2013 Q2
35 quarters
MS icon
77
Morgan Stanley
MS
$283B
$8.27M 0.36%
94,610
+154
+0.2% +$14.9K
2013 Q2
35 quarters
VB icon
78
Vanguard Morningstar Small-Cap ETF
VB
$76.7B
$8.21M 0.36%
38,609
+500
+1% +$105K
2019 Q1
12 quarters
IBB icon
79
iShares Biotechnology ETF
IBB
$10.3B
$8.11M 0.35%
62,234
-4,626
-7% -$603K
2013 Q2
35 quarters
BMY icon
80
Bristol-Myers Squibb
BMY
$124B
$8.01M 0.35%
109,735
+2,432
+2% +$163K
2013 Q2
35 quarters
TGT icon
81
Target
TGT
$70B
$7.99M 0.35%
37,653
+581
+2% +$126K
2019 Q2
11 quarters
WFC icon
82
Wells Fargo
WFC
$251B
$7.91M 0.34%
163,262
-11,828
-7% -$633K
2013 Q2
35 quarters
NKE icon
83
Nike
NKE
$54.9B
$7.87M 0.34%
58,476
+270
+0.5% +$37.9K
2013 Q2
35 quarters
TMO icon
84
Thermo Fisher Scientific
TMO
$254B
$7.87M 0.34%
13,320
+236
+2% +$136K
2013 Q2
35 quarters
INTU icon
85
Intuit
INTU
$86.3B
$7.81M 0.34%
16,246
+354
+2% +$181K
2013 Q2
35 quarters
AMGN icon
86
Amgen
AMGN
$234B
$7.81M 0.34%
32,282
-296
-0.9% -$68K
2019 Q2
11 quarters
ACN icon
87
Accenture
ACN
$138B
$7.73M 0.34%
22,935
+416
+2% +$140K
2013 Q2
35 quarters
GS icon
88
Goldman Sachs
GS
$256B
$7.66M 0.33%
23,204
+98
+0.4% +$34.6K
2013 Q2
35 quarters
VFH icon
89
Vanguard Financials ETF
VFH
$13.1B
$7.41M 0.32%
79,312
+1,879
+2% +$180K
2013 Q2
35 quarters
VOX icon
90
Vanguard Communication Services ETF
VOX
$5.96B
$7.35M 0.32%
61,210
-4,718
-7% -$578K
2013 Q2
35 quarters
LMT icon
91
Lockheed Martin
LMT
$126B
$6.97M 0.3%
15,799
+134
+0.9% +$54.3K
2013 Q2
35 quarters
CVS icon
92
CVS Health
CVS
$118B
$6.73M 0.29%
66,534
+1,858
+3% +$195K
2013 Q2
35 quarters
RTX icon
93
RTX Corp
RTX
$259B
$6.71M 0.29%
67,774
-1,016
-1% -$96.3K
2019 Q1
12 quarters
DXCM icon
94
DexCom
DXCM
$32.4B
$6.51M 0.28%
50,872
-5,108
-9% -$559K
2014 Q1
32 quarters
IWC icon
95
iShares Micro-Cap ETF
IWC
$1.25B
$6.36M 0.28%
49,363
-5,480
-10% -$704K
2013 Q2
35 quarters
CRM icon
96
Salesforce
CRM
$198B
$6.23M 0.27%
29,352
+765
+3% +$165K
2013 Q3
34 quarters
USB icon
97
US Bancorp
USB
$91B
$6.21M 0.27%
116,770
+846
+0.7% +$48.6K
2013 Q2
35 quarters
AMAT icon
98
Applied Materials
AMAT
$329B
$6.16M 0.27%
46,763
+712
+2% +$98K
2019 Q2
11 quarters
AVGO icon
99
Broadcom
AVGO
$1.58T
$6.13M 0.27%
97,420
+5,840
+6% +$347K
2015 Q4
25 quarters
VV icon
100
Vanguard Morningstar Large-Cap ETF
VV
$54.1B
$6.01M 0.26%
28,823
-13
-0% -$2.67K
2013 Q2
35 quarters
2 3
4
5 6

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
Covington Capital Management
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
Mariner Independent Advisor Network
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q1 2022 Portfolio in Review

As of Q1 2022, Dowling & Yahnke held 391 positions worth $2.3B, up 11% from $2.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Dowling & Yahnke deployed $315M of net new capital in Q1 2022, opening 14 new positions and adding to 187 existing holdings. Its largest new stake was Vanguard Tax-Exempt Bond Index Fund: 2,946,917 shares worth $152M.

By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, up from 37% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Reliance Steel & Aluminium, an estimated $2.36M trimmed.

  • Dowling & Yahnke's largest Q1 2022 buy was Vanguard Tax-Exempt Bond Index Fund: 2,946,917 shares worth $152M.
  • Dowling & Yahnke added most to Vanguard Short-Term Bond ETF in Q1 2022, an estimated $27.5M increase.
  • Dowling & Yahnke's biggest Q1 2022 reduction was Reliance Steel & Aluminium, cutting an estimated $2.36M.
  • Dowling & Yahnke fully exited JPMorgan Ultra-Short Income ETF in Q1 2022, selling an estimated $828K.
  • Dowling & Yahnke's ten largest holdings make up 30% of its $2.3B portfolio in Q1 2022.
  • Dowling & Yahnke opened 14 new positions and closed 16 in Q1 2022.
  • Dowling & Yahnke's portfolio value rose 11% quarter-over-quarter to $2.3B.

Based on Dowling & Yahnke's 13F filing for Q1 2022, filed 4 May 2022.